A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy

References

• Ohira A, Ueda T, Ohishi K, et al. [Oxidative stress in ocular disease]. Nippon Ganka Gakkai zasshi 2008;112:22–9
   PubMedGoogle Scholar
• Wakamatsu TH, Dogru M, Ayako I, et al. Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease. Mol Vis 2010;16:2465–75
   PubMed Web of Science ®Google Scholar
• Blasiak J, Petrovski G, Vereb Z, et al. Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration. BioMed Res Int 2014;2014:768026
   PubMed Web of Science ®Google Scholar
• Hashim Z, Zarina S. Osmotic stress induced oxidative damage: possible mechanism of cataract formation in diabetes. J Diabetes Complications 2012;26:275–9
   PubMed Web of Science ®Google Scholar
• Saraswathy S, Rao NA. Photoreceptor mitochondrial oxidative stress in experimental autoimmune uveitis. Ophthal Res 2008;40:160–4
   PubMed Web of Science ®Google Scholar
• Wojcik KA, Kaminska A, Blasiak J, et al. Oxidative stress in the pathogenesis of keratoconus and Fuchs endothelial corneal dystrophy. Int J Mol Sci 2013;14:19294–308
   PubMed Web of Science ®Google Scholar
• Ribeiro A, Sandez-Macho I, Casas M, et al. Poloxamine micellar solubilization of alpha-tocopherol for topical ocular treatment. Colloids Surfaces B Biointerf 2013;103:550–7
   PubMed Web of Science ®Google Scholar
• Alexander LJ. Ocular vitamin therapy. A review and assessment. Optom Clin 1992;2:1–34
   PubMedGoogle Scholar
• Bartlett H, Eperjesi F. Possible contraindications and adverse reactions associated with the use of ocular nutritional supplements. Ophthal Physiol Optics 2005;25:179–94
   PubMed Web of Science ®Google Scholar
• Long L, Cai XD, Bao J, et al. Total parenteral nutrition caused Wernicke's encephalopathy accompanied by wet beriberi. Am J Case Rep 2014;15:52–5
   PubMedGoogle Scholar
• Muntz JE, Michota FA. Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors. Am J Surg 2010;199:S11–20
   PubMed Web of Science ®Google Scholar
• Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 2005;6:165–73
   PubMed Web of Science ®Google Scholar
• Liu N, Park HJ. Chitosan-coated nanoliposome as vitamin E carrier. J Microencapsulat 2009;26:235–42
   PubMed Web of Science ®Google Scholar
• Alayoubi A, Abu-Fayyad A, Rawas-Qalaji MM, et al. Effect of lipid viscosity and high-pressure homogenization on the physical stability of “Vitamin E” enriched emulsion. Pharm Dev Technol 2015;20:555–61
   PubMed Web of Science ®Google Scholar
• Gong Y, Wu Y, Zheng C, et al. An excellent delivery system for improving the oral bioavailability of natural vitamin E in rats. AAPS PharmSciTech 2012;13:961–6
   PubMed Web of Science ®Google Scholar
• Morais JM, Burgess DJ. In vitro release testing methods for vitamin E nanoemulsions. Int J Pharm 2014;475:393–400
   PubMed Web of Science ®Google Scholar
• Lallemand F, Daull P, Benita S, et al. Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. J Drug Deliv 2012;2012:604204
   PubMedGoogle Scholar
• Ilahi I, Samar S, Khan I, Ahmad I. In vitro antioxidant activities of four medicinal plants on the basis of DPPH free radical scavenging. Pakistan J Pharm Sci 2013;26:949–52
   PubMed Web of Science ®Google Scholar
• Almeida IF, Costa PC, Bahia MF. Optimization of a surfactant-free antioxidant formulation using response surface methodology. Drug Dev Indus Pharm 2014;40:120–5
   PubMed Web of Science ®Google Scholar
• Basu Ray G, Chakraborty I, Moulik SP. Pyrene absorption can be a convenient method for probing critical micellar concentration (cmc) and indexing micellar polarity. J Colloid Interface Sci 2006;294:248–54
   PubMed Web of Science ®Google Scholar
• Diebold Y, Jarrin M, Saez V, et al. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 2007;28:1553–64
   PubMed Web of Science ®Google Scholar
• Gan L, Han S, Shen J, et al. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm 2010;396:179–87
   PubMed Web of Science ®Google Scholar
• Jiao J. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Adv Drug Deliv Rev 2008;60:1663–73
   PubMed Web of Science ®Google Scholar
• Yao M, Xiao H, McClements DJ. Delivery of lipophilic bioactives: assembly, disassembly, and reassembly of lipid nanoparticles. Annu Rev Food Sci Technol 2014;5:53–81
   PubMed Web of Science ®Google Scholar
• Sznitowska M, Janicki S, Dabrowska EA, Gajewska M. Physicochemical screening of antimicrobial agents as potential preservatives for submicron emulsions. Eur J Pharm Sci 2002;15:489–95
   PubMed Web of Science ®Google Scholar
• Daull P, Lallemand F, Garrigue JS. Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. J Pharm Pharmacol 2014;66:531–41
   PubMed Web of Science ®Google Scholar
• Almeida H, Amaral MH, Lobao P, Lobo JM. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discov Today 2014;19:400–12
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohe R. Vitamin E: the shrew waiting to be tamed. Free Radic Biol Med 2009;46:543–54
   PubMed Web of Science ®Google Scholar
• Morais Diane JM, Burgess J. Vitamin E nanoemulsions characterization and analysis. Int J Pharm 2014;465:455–63
   PubMed Web of Science ®Google Scholar
• Lu Y, Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm 2013;453:198–214
   PubMed Web of Science ®Google Scholar
• Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013;39:1599–617
   PubMed Web of Science ®Google Scholar
• Cortesi R, Argnani R, Esposito E, et al. Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity. Int J Pharm 2006;317:90–100
   PubMed Web of Science ®Google Scholar
• Luschmann C, Herrmann W, Strauss O, et al. Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation. Int J Pharm 2013;455:331–7
   PubMed Web of Science ®Google Scholar
• Rabinovich-Guilatt L, Couvreur P, Lambert G, Dubernet C. Cationic vectors in ocular drug delivery. J Drug Target 2004;12:623–33
   PubMed Web of Science ®Google Scholar
• Liang H, Brignole-Baudouin F, Rabinovich-Guilatt L, et al. Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits. Mol Vis 2008;14:204–16
   PubMed Web of Science ®Google Scholar
• Baudouin C, de Lunardo C. Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers. Br J Ophthalmol 1998;82:39–42
   PubMed Web of Science ®Google Scholar
• Ciancaglini M, Carpineto P, Agnifili L, et al. Conjunctival modifications in ocular hypertension and primary open angle glaucoma: an in vivo confocal microscopy study. Investig Ophthalmol Vis Sci 2008;49:3042–8
   PubMed Web of Science ®Google Scholar
• Liang H, Baudouin C, Daull P, et al. Ocular safety of cationic emulsion of cyclosporine in an in vitro corneal wound-healing model and an acute in vivo rabbit model. Mol Vis 2012;18:2195–204
   PubMed Web of Science ®Google Scholar
• Liang H, Baudouin C, Daull P, et al. In vitro and in vivo evaluation of a preservative-free cationic emulsion of latanoprost in corneal wound healing models. Cornea 2012;31:1319–29
   PubMed Web of Science ®Google Scholar